EUVIMEDEUVIMED entdecken
Crossref

Relevance of high sensitivity C-reactive protein levels in short term outcome in patients with acute coronary syndrome

European Journal of Clinical Pharmacy · 21.03.2025 · 7 (1) · 8515-8519

DOI: 10.61336/ejcp/25-08-548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 21.03.2025.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To determine the relevance of high sensitivity C-reactive protein levels in short term outcome in patients with acute coronary syndrome.Study Design: A Cohort study.Place and duration of study: This study was conducted at the department of Cardiology, Shifa International Hospital Islamabad, Pakistan over a period of 4 months from 21st of Feb 2023 to 23rd of June 2023.Methodology: A total of 58 adult patients diagnosed with ACS and had their hs-CRP levels ˃3 mg/l were enrolled in group-A while other 58 adult patients diagnosed with ACS and had their hs-CRP levels ≤ 3 mg/l were enrolled in Group-B through consecutive sampling method.All patients received optimal medical therapy based on the evidence. The clinical follow-ups were done at 2 weeks, 1 month, 2 months, and 4 months (final follow up visit). Events like STEMI, NSTEMI, unstable angina or CV mortality were taken as primary short term outcomes.

Results

The Mean±SD of age in this study was 61.40±10.15 years. The number of male gender was equal to female gender in overall study population. The Mean±SD of hs-CRP was 4.46±1.01 and1.85±0.56 in Group-A and Group-B respectively. Results of the study showed significantly higher incidence of primary outcomes in Group-A (29.31%) compared to Group-B (8.62%) at the end of 4 months follow up period, p=0.003 (STEMI: 8.62% Vs 3.44%, p=0.242, NSTEMI: 6.89% Vs 1.72%, p=0.170, Unstable angina: 10.34% Vs 1.72%, p=0.05, CV mortality3.44% Vs 1.72%, p=0.55 for Group-A and Group-B respectively).

Conclusions

The results of this study conclude that base line hs-CRP levels are significantly associated with the short term outcomes in patients with ACS.

Zitieren

APA

(2025). Relevance of high sensitivity C-reactive protein levels in short term outcome in patients with acute coronary syndrome. European Journal of Clinical Pharmacy, 7(1), 8515-8519. https://doi.org/10.61336/ejcp/25-08-548

Vancouver

Relevance of high sensitivity C-reactive protein levels in short term outcome in patients with acute coronary syndrome. European Journal of Clinical Pharmacy. 2025;7(1):8515-8519. doi:10.61336/ejcp/25-08-548

BibTeX
@article{euvimed2025,
  title = {Relevance of high sensitivity C-reactive protein levels in short term outcome in patients with acute coronary syndrome},
  journal = {European Journal of Clinical Pharmacy},
  year = {2025},
  volume = {7},
  number = {1},
  pages = {8515--8519},
  doi = {10.61336/ejcp/25-08-548}
}
Kostenlos starten →